What we know about paracentesis induced circulatory dysfunction? - Wikidata - wikimedia - TriplyDB

What we know about paracentesis induced circulatory dysfunction?

What we know about paracentesis induced circulatory dysfunction?

http://www.wikidata.org/entity/Q43089477

about

What we know about paracentesis induced circulatory dysfunction?

http://www.wikidata.org/entity/Q43089477

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

What we know about paracentesis induced circulatory dysfunction?

@en

What we know about paracentesis induced circulatory dysfunction?

@nl

type

label

What we know about paracentesis induced circulatory dysfunction?

@en

What we know about paracentesis induced circulatory dysfunction?

@nl

prefLabel

What we know about paracentesis induced circulatory dysfunction?

@en

What we know about paracentesis induced circulatory dysfunction?

@nl

P1433

Q43089477-499C6D53-F6D1-4193-9E23-D976B43C6A63

P1476

Q43089477-584BA8DC-E419-439F-A882-DD676DE98E9C

P2093

Q43089477-E537F5BA-08DD-4C22-9C06-E303B783EEF1

P2860

Q43089477-167625E9-DFA6-4B16-B8F2-D657D09745C7

Q43089477-33D0E05F-D3EF-4962-A702-E998DB4F3133

Q43089477-3FA59363-5D85-4AF5-A94E-E9786CBC5248

Q43089477-4BBE2D2F-5BAC-48DF-A3B1-1B01DB730264

Q43089477-555DBCA7-DD5C-4FEB-91C6-A2D99C284E97

Q43089477-74DFE3B1-2BAB-491E-B3B6-436B9B7FDECC

Q43089477-7EC08000-4348-4161-8044-BC2F15A46272

Q43089477-822A76A8-27C1-4AE2-9529-2CFE564B8131

Q43089477-8E8336C4-E03E-4F75-9E1F-23D2E5A2A722

Q43089477-9DCA969F-BD36-4A63-AEC3-7D6998AED2B9

P304

Q43089477-8F62F933-01F1-4608-92E0-D9C38AF40419

P31

Q43089477-0C55D84F-5A1B-4C68-9B26-F1DC6620F6F5

Q43089477-d135e3d2-6c14-4818-8255-e358062ea901

P356

Q43089477-65338573-6C67-4120-BE48-247FFBCA0546

P433

Q43089477-84498731-74FF-4891-A46E-CC4F0767BC6C

P478

Q43089477-16A0A123-FDC2-4F98-8220-D5808B0E4AB3

P577

Q43089477-41851B06-B158-47F5-9EFA-E7178E78A64B

P5875

Q43089477-8A0D8EC7-E39D-4F54-BA60-EE369DCCD538

P698

Q43089477-0C4BECD0-F8D1-473E-A201-FCB8FE758AAB

P932

Q43089477-BC149182-86E9-42D3-813B-58EE9CF38850

P356

CMH.2015.21.4.349

P1433

Clinical and molecular hepatology

P1476

What we know about paracentesis induced circulatory dysfunction?

@en

P2093

Jeong Han Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines on the management of ascites in cirrhosis

Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials.

Revision and update on clinical practice guideline for liver cirrhosis.

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications.

Paracentesis-induced circulatory dysfunction: a primer for the interventional radiologist.

Mechanisms of early decrease in systemic vascular resistance after total paracentesis: influence of flow rate of ascites extraction.

P304

349-351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3350/CMH.2015.21.4.349

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

290471331

http://www.w3.org/2001/XMLSchema#string

P698

26770922

http://www.w3.org/2001/XMLSchema#string

P932

4712161

http://www.w3.org/2001/XMLSchema#string